297 related articles for article (PubMed ID: 11657840)
1. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information.
Samuels A
Account Res; 1999; 6(4):259-310. PubMed ID: 11657840
[No Abstract] [Full Text] [Related]
2. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
3. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
4. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
5. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
6. Federal agency revises rule on financial disclosure by researchers.
Maloney DM
Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
[No Abstract] [Full Text] [Related]
7. Bioethics and applied biomaterials.
Saha S; Saha P
J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
[No Abstract] [Full Text] [Related]
8. Corporate corruption of medical literature: asbestos studies concealed by W.R. Grace & Co.
Egilman D; Wallace W; Hom C
Account Res; 1998 Jan; 6(1-2):127-47. PubMed ID: 11660587
[No Abstract] [Full Text] [Related]
9. Animal models in biomedical research: some epistemological worries.
LaFollette H; Shanks N
Public Aff Q; 1993 Apr; 7(2):113-30. PubMed ID: 11652915
[No Abstract] [Full Text] [Related]
10. Worries about animal models in biomedical research: a response to LaFollette and Shanks.
Willis LR; Hulsey MG
Public Aff Q; 1994 Apr; 8(2):205-18. PubMed ID: 11652920
[No Abstract] [Full Text] [Related]
11. The role and responsibility of industry in research.
Lasagna L
Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
[No Abstract] [Full Text] [Related]
12. Ethical oxymora for risk assessment practitioners.
Greenberg MR; Spiro H; McIntyre R
Account Res; 1991; 1(4):245-57. PubMed ID: 11651458
[No Abstract] [Full Text] [Related]
13. Ethical values in the education of biomedical researchers.
Heitman E
Hastings Cent Rep; 2000; 30(4 Suppl):S40-4. PubMed ID: 11658244
[No Abstract] [Full Text] [Related]
14. Data audit by a regulatory agency: its effect and implication for others.
Shapiro MF
Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
[No Abstract] [Full Text] [Related]
15. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
16. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
Lehrman S
Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
[No Abstract] [Full Text] [Related]
17. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
18. Conflicts of interest.
Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
[No Abstract] [Full Text] [Related]
19. International research agreement leads to new U.S. guidelines.
Maloney DM
Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
[No Abstract] [Full Text] [Related]
20. Proprietary rights and the norms of science in biotechnology research.
Eisenberg RS
Yale Law J; 1987 Dec; 97(2):177-231. PubMed ID: 11660398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
